Stocks IDXG

Singer Douglas Mark Increases Position in Interpace Diagnostics Group (IDXG)

Fintel reports that Singer Douglas Mark has filed a 13G/A form with the SEC disclosing ownership of 0.36MM shares of Interpace Diagnostics Group, Inc. (IDXG). This represents 8.32% of the company.

In their previous filing dated February 10, 2022 they reported 0.29MM shares and 6.98% of the company, an increase in shares of 21.22% and an increase in total ownership of 1.34% (calculated as current - previous percent ownership).

Analyst Price Forecast Suggests 560.00% Upside

As of February 9, 2023, the average one-year price target for Interpace Diagnostics Group is $11.22. The forecasts range from a low of $11.11 to a high of $11.55. The average price target represents an increase of 560.00% from its latest reported closing price of $1.70.

The projected annual revenue for Interpace Diagnostics Group is $51MM, an increase of 24.88%. The projected annual EPS is -$2.76.

What is the Fund Sentiment?

There are 1 funds or institutions reporting positions in Interpace Diagnostics Group. This is a decrease of 5 owner(s) or 83.33% in the last quarter. Average portfolio weight of all funds dedicated to IDXG is 0.00%, a decrease of 27.84%. Total shares owned by institutions decreased in the last three months by 61.34% to 0K shares.

What are large shareholders doing?

IDXG / Interpace Diagnostics Group, Inc. Ownership

JETSX - Total Stock Market Index Trust NAV holds 0K shares representing 0.01% ownership of the company. No change in the last quarter.

This story originally appeared on Fintel.

Fintel
Fintel is a leading provider of financial data and insights for intelligent, data-driven investors. With coverage of over 75,000 listed companies on all major stock exchanges, Fintel has the most comprehensive coverage of global equities at prices individual investors can afford.
Check out our Unique Analysis of Insider Sentiment for Interpace Diagnostics Group, Inc. Find out what the Options Markets think of Interpace Diagnostics Group, Inc. See our take on Interpace Diagnostics Group, Inc. Upcoming Earnings More articles by this source

Tags

Stocks Mentioned

Latest Articles

Data is currently not available